News Roundup: November 7 to November 11
Your weekly roundup of the latest news from Drug Topics®.
Tips for Tackling PBM Audits—Together
Working collaboratively can be key to either avoiding a PBM audit altogether or making the process as painless as possible.
Impact of Guideline Changes on Opioid Use in Childhood Cancer Survivors
Childhood cancer survivors are high risk of pain and in need of pain relief. Did 2016 guidelines for opioid prescribing change use in this group?
Tackling Pneumonia in the Pharmacy
Besides providing education and counseling, pharmacists play a key role in the administration of vaccines.
Improving Vaccine Uptake Requires More Than a ‘One Size Fits All’ Approach
Addressing hesitancy is more than just offering pertinent information.
Are Cannabinoids Key to Harm Reduction in Opioid Use Disorder?
Cannabinoids lack the habit-forming mechanism of action found in methadone and buprenorphine, unlocking new potential for the drug.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
